TNFRSF10B and cancer: A multimeric anti-DR5 IgM agonist antibody, characterized by its high-affinity binding to DR5, effectively induces apoptosis in cancer cells through the promotion of DR5 multimerization (Wang et al., 2021b; Classic, 2018b)